Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study

Annals of the Rheumatic Diseases

Volumn 75, Issue 1, 2016, Pages 103-109

  Avouac, Jérôme ^a   Walker, Ulrich A ^b   Hachulla, Eric ^c   Riemekasten, Gabriela ^d   Cuomo, Giovanna ^e   Carreira, Patricia E ^f   Caramaschi, Paola ^g   Ananieva, Lidia P ^h   Matucci Cerinic, Marco ⁱ   Czirjak, Laszlo ^j   Denton, Christopher ^k   Ladner, Ulf Müller ^l   Allanore, Yannick ^a   Guiducci, Serena ⁱ   Tyndall, Alan ^b   Lapadula, Giovanni ^m   Iannone, Florenzo ^m   Distler, Oliver ^m   Becvar, Radim ^m   Sierakowsky, Stanislaw ^m   Bielecka, Otylia Kowal ^m   Cutolo, Maurizio ^m   Sulli, Alberto ^m   Valentini, Gabriele ^m   Rednic, Simona ^m   Nicoara, Ileana ^m   Vlachoyiannopoulos, Panayiotis G ^m   Montecucco, Carlomaurizio ^m   Caporali, Roberto ^m   Novak, Srdan ^m   Chizzolini, Carlo ^m   Kucharz, Eugene J ^m   Kotulska, Anna ^m   Cozzi, Franco ^m   Rozman, Blaz ^m   Mallia, Carmel ⁿ   Coleiro, Bernard ⁿ   Gabrielli, Armando ^m   Farge Bancel, Dominique ^a   Hadj Khelifa, Sondess ^a   Airò, Paolo ^m   Hesselstrand, Roger ^m   Scheja, Agneta ^m   Martinovic, Duska ^m   Gurman, Alexandra Balbir ^m   Braun Moscovici, Yolanda ^m   Hunzelmann, Nicolas ^m   Pellerito, Raffaele ^m   Bambara, Lisa Maria ^g   Morovic Vergles, Jadranka ^m   Black, Carol ^k   Damjanov, Nemanja ^m   Kötter, Ina ^m   Santamaria, Vera Ortiz ^m   Heitmann, Stefan ^m   Krasowska, Dorota ^m   Seidel, Matthias ^m   Hasler, Paul ^m   Burkhardt, Harald ^m   Himsel, Andrea ^m   Da Silva, José Antonio Pereira ^m   Salvador, Maria João ^m   Stamenkovi, Bojana ^m   Stankovic, Aleksandra ^m   Marasini, Bianca ^m   Belloli, Laura ^m   Tikly, Mohammed ^m   Denisov, Lev N ^h   Scorza, Raffaella ^m   Engelhart, Merete ^m   Strauss, Gitte ^m   Szücs, Gabriella ^m   Szamosi, Szilvia ^m   De La Puente, Carlos ^f   De La Peña Lefebvre, Paloma García ^f   Midtvedt, Øyvind ^m   Garen, Torhild ^m   Launay, David ^c   Valesini, Guido ^m   Riccieri, Valeria ^m   Ionescu, Ruxandra Maria ^m   Opris, Daniela ^m   Wigley, Fredrick M ^m   Stoica, Viktor ^m   Mihai, Carmen Marina ^m   Distler, Jörg ^m   Meroni, Pierluigi ^m   Zeni, Silvana ^m   Mouthon, Luc ^a   Smith, Vanessa ^m   Cantatore, Francesco Paolo ^m   Corrado, Ada ^m   Ullman, Susanne ^m   Iversen, Line ^m   Pozzi, Maria Rosa ^m   Eyerich, Kilian ^m   Hein, Rüdiger ^m   Szechinski, Jacek ^m   Wiland, Piotr ^m   Krummel Lorenz, Brigitte ^m   Aringer, Martin ^m   Westhovens, Rene ^m   De Langhe, Ellen ^m   Anic, Branimir ^m   Baresi, Marko ^m   Üprus, Maria ^o   Otsa, Kati ^o   Yavuz, Sule ^m   Radominski, Sebastião Cezar ^m   De Souza Müller, Carolina ^m   Jimenez, Sergio ^m   Busquets, Joanna ^m   Popa, Sergei ^m   Agachi, Svetlana ^m   Zenone, Thierry ^m   Mathieu, Alessandro ^m   Vacca, Alessandra ^m   Stamp, Lisa ^m   Chapman, Peter ^m   Tanaseanu, Cristina Mihaela ^m   Popescu, Monica ^m   Foti, Rosario ^m   Rubio, Silvia Rodriguez ^f   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIV LILLE   (France)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g UNIVERSITY HOSPITAL OF VERONA   (Italy)

^h V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

^j UNIVERSITY OF PÉCS   (Hungary)

^k ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^l JUSTUS LIEBIG UNIVERSITY   (Germany)

^m NONE   (Italy)

ⁿ NONE   (Slovenia)

^o NONE   (Estonia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; ANTIBODY; DNA TOPOISOMERASE; TOP1 PROTEIN, HUMAN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FINGER ULCER; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTERSTITIAL LUNG DISEASE; KIDNEY DISEASE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SYNOVITIS; SYSTEMIC SCLEROSIS; TENDON DISEASE; TENDON FRICTION RUBS; AGED; BLOOD; COMPLICATION; FOLLOW UP; FRICTION; HEART LEFT VENTRICLE FUNCTION; IMMUNOLOGY; KIDNEY DISEASES; LUNG DISEASES, INTERSTITIAL; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY FIBROSIS; RADIOGRAPHY; SKIN ULCER; TENDON;

ADULT; AGED; ANTIBODIES; DISEASE PROGRESSION; DNA TOPOISOMERASES, TYPE I; FEMALE; FOLLOW-UP STUDIES; FRICTION; HUMANS; KIDNEY DISEASES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUSCLE WEAKNESS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC; SKIN ULCER; SYNOVITIS; TENDONS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84954441382     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205295     Document Type: Article

References (28)

1. Allanore Y, Avouac J, Wipff J, et al. New therapeutic strategies in the management of systemic sclerosis. Expert Opin Pharmacother 2007;8:607-15.
2. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989-2003.
3. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-44.
4. Elhai M, Meune C, Avouac J, et al. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2012;51:1017-26.
5. Matucci-Cerinic M, Allanore Y, Czirjak L, et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis 2009;68:1377-80.
6. Avouac J, Walker U, Tyndall A, et al. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol 2010;37:1488-501.
7. Steen VD, Medsger TA Jr. The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis. Arthritis Rheum 1997;40:1146-51.
8. Dore A, Lucas M, Ivanco D, et al. Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis. Arthritis Care Res (Hoboken) 2013;65:1385-9.
9. Walker UA, Tyndall A, Czirjak L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007;66:754-63.
10. Meier FM, Frommer KW, Dinser R, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2012;71:1355-60.
11. Walker UA, Tyndall A, Czirjak L, et al. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Ann Rheum Dis 2009;68:856-62.
12. Allanore Y, Meune C, Vonk MC, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010;69:218-21.
13. [No authors listed]. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Bull Rheum Dis 1981;31:1-6.
14. Elhai M, Guerini H, Bazeli R, et al. Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic, and radiographic findings. Arthritis Care Res (Hoboken) 2012;64:1244-9.
15. Avouac J, Airo P, Meune C, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 2010;37:2290-8.
16. Avouac J, Meune C, Ruiz B, et al. Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis. Ann Rheum Dis 2012;71:394-9.
17. [No authors listed]. Proceedings of the 4th World Symposium on Pulmonary Hypertension, February 2008, Dana Point, California, USA. J Am Coll Cardiol 2009;54:S1-117.
18. Khanna PP, Furst DE, Clements PJ, et al. Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial. Rheumatology (Oxford) 2010;49:955-9.
19. Domsic RT, Rodriguez-Reyna T, Lucas M Jr, et al. Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis 2011;70:104-9.
20. Amjadi S, Maranian P, Furst DE, et al. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis Rheum 2009;60:2490-8.
21. Hachulla E, Clerson P, Launay D, et al. Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. J Rheumatol 2007;34:2423-30.
22. Tiev KP, Diot E, Clerson P, et al. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinerAIR-Sclerodermie). J Rheumatol 2009;36:1470-6.
23. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005;35:35-42.
24. Cottrell TR, Wise RA, Wigley FM, et al. The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis. Ann Rheum Dis 2014;73:1060-6.
25. Allanore Y, Borderie D, Avouac J, et al. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum 2008;58:284-91.
26. Behr J, Furst DE. Pulmonary function tests. Rheumatology (Oxford) 2008;47(Suppl 5):v65-7.
27. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013;72:1747-55.
28. Matucci-Cerinic M, Bellando-Randone S, Lepri G, et al. Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. Ann Rheum Dis 2013;72:319-21.